Recent Advances in Biomaterials for the Treatment of Bone Defects

被引:45
作者
Zhang, Le-Yi [1 ]
Bi, Qing [2 ]
Zhao, Chen [2 ]
Chen, Jin-Yang [3 ]
Cai, Mao-Hua [1 ]
Chen, Xiao-Yi [4 ,5 ]
机构
[1] Zhejiang Prov Peoples Hosp, Dept Gen Surg, Chunan First Peoples Hosp, Chunan Branch, 1869 Huanhu North Rd, Hangzhou 311700, Zhejiang, Peoples R China
[2] Zhejiang Prov Peoples Hosp, Dept Orthoped, Peoples Hosp, Hangzhou Med Coll, Hangzhou, Peoples R China
[3] Zhejiang Healthfuture Inst Cell Based Appl Techno, Res & Dev Dept, Hangzhou, Zhejiang, Peoples R China
[4] Zhejiang Prov Peoples Hosp, Peoples Hosp, China Clin Res Inst,Hangzhou Med Coll, Key Lab Tumor Mol Diag & Individualized Med Zheji, Hangzhou, Peoples R China
[5] Zhejiang Prov Peoples Hosp, Clin Res Inst, Peoples Hosp, Hangzhou Med Coll, Hangzhou 310014, Peoples R China
关键词
Biomaterials; bone regeneration; regenerative medicine; bio-scaffolds; bone remodeling; MESENCHYMAL STEM-CELLS; IN-VITRO; OSTEOCHONDRAL DEFECTS; REPAIR; MARROW; REGENERATION; SCAFFOLDS; CARTILAGE; DELIVERY; MACROPHAGES;
D O I
10.1080/15476278.2020.1808428
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bone defects or fractures generally heal in the absence of major interventions due to the high regenerative capacity of bone tissue. However, in situations of severe/large bone defects, these orchestrated regeneration mechanisms are impaired. With advances in modern medicine, natural and synthetic bio-scaffolds from bioceramics and polymers that support bone growth have emerged and gained intense research interest. In particular, scaffolds that recapitulate the molecular cues of extracellular signals, particularly growth factors, offer potential as therapeutic bone biomaterials. The current challenges for these therapies include the ability to engineer materials that mimic the biological and mechanical properties of the real bone tissue matrix, whilst simultaneously supporting bone vascularization. In this review, we discuss the very recent innovative strategies in bone biomaterial technology, including those of endogenous biomaterials and cell/drug delivery systems that promote bone regeneration. We present our understanding of their current value and efficacy, and the future perspectives for bone regenerative medicine.
引用
收藏
页码:113 / 125
页数:13
相关论文
共 93 条
[1]  
Ahmed E, 2018, FRONT BIOENG BIOTECH, V79
[2]   Cowries derived aragonite as raw biomaterials for bone regenerative medicine [J].
Akilal, N. ;
Lemaire, F. ;
Bercu, N. B. ;
Sayen, S. ;
Gangloff, S. C. ;
Khelfaoui, Y. ;
Rammal, H. ;
Kerdjoudj, H. .
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2019, 94 :894-900
[3]   Osteo-chondroprogenitor cells are derived from Sox9 expressing precursors [J].
Akiyama, H ;
Kim, JE ;
Nakashima, K ;
Balmes, G ;
Iwai, N ;
Deng, JM ;
Zhang, ZP ;
Martin, JF ;
Behringer, RR ;
Nakamura, T ;
de Crombrugghe, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (41) :14665-14670
[4]  
Albeshri Sultan, 2018, J Contemp Dent Pract, V19, P605
[5]  
Amini Ami R., 2012, Critical Reviews in Biomedical Engineering, V40, P363
[6]  
Astori G, 2010, AM J TRANSL RES, V2, P285
[7]   Cellular biology of fracture healing [J].
Bahney, Chelsea S. ;
Zondervan, Robert L. ;
Allison, Patrick ;
Theologis, Alekos ;
Ashley, Jason W. ;
Ahn, Jaimo ;
Miclau, Theodore ;
Marcucio, Ralph S. ;
Hankenson, Kurt D. .
JOURNAL OF ORTHOPAEDIC RESEARCH, 2019, 37 (01) :35-50
[8]   Interleukin-1 signal transduction [J].
BankersFulbright, JL ;
Kalli, KR ;
McKean, DJ .
LIFE SCIENCES, 1996, 59 (02) :61-83
[9]   Sox9 is required for cartilage formation [J].
Bi, WM ;
Deng, JM ;
Zhang, ZP ;
Behringer, RR ;
de Crombrugghe, B .
NATURE GENETICS, 1999, 22 (01) :85-89
[10]   In vitro evaluation of a biomaterial-based anticancer drug delivery system as an alternative to conventional post-surgery bone cancer treatment [J].
Bischoff, Iris ;
Tsaryk, Roman ;
Chai, Feng ;
Fuerst, Robert ;
Kirkpatrick, Charles James ;
Unger, Ronald E. .
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2018, 93 :115-124